Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the Lung
Michael C. Perry, Walter L. Eaton, KATHLEEN JOY PROPERT et al. · New England Journal of Medicine · 1987
We conducted a prospective, randomized study to clarify the role of radiotherapy of the primary tumor in limited small-cell cancer of the lung. After stratification for sex and for performance score based on the ability to ambulate, patients were randomly assigned to receive initial radiotherapy plus chemotherapy, delayed radiotherapy plus chemotherapy, or chemotherapy alone. The chemotherapy consisted of cyclophosphamide, etoposide (VP-16-213), and vincristine, with doxorubicin subsequently replacing etoposide in alternate cycles 7 through 18. Chemotherapy was given every three weeks for 18 months. The radiotherapy comprised 4000 rad in four weeks, followed by a 1000-rad "boost" directed against residual disease. All patients received prophylactic whole-brain radiation. The patients enrolled totaled 426, and 399 were evaluable. There was a statistically significant difference in the frequency of complete responses in favor of the two radiotherapy regimens (P = 0.0013). Failure-free survival was also longer with these two regimens (P less than 0.001), as was the interval before treatment failure in the chest (P less than 0.001) and overall survival (P = 0.0099). As expected, toxic effects--chiefly neutropenia--were also increased. The addition of radiotherapy of the primary tumor to combination chemotherapy improved both complete-response rates and survival, with increased but acceptable toxicity.
Cited by 482 works. doi:10.1056/nejm198704093161504
Authors
- Michael C. Perry
- Walter L. Eaton
- KATHLEEN JOY PROPERT
- James H. Ware
- Bonnie Zimmer
- A. Philippe Chahinian
- Arthur T. Skarin
- Robert W. Carey
- Harvey Kreisman
- Charles S. Faulkner
- Robert L. Comis
- Mark R. Green
References
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
- The World Health Organization Histological Typing of Lung Tumours: Second Edition
- Small cell lung cancer 1973–1983: Early progress and recent obstacles
- A randomized combined modality trial in small cell carcinoma of the lung comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation
- Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report.
- Small cell lung cancer: progress and perspectives.
- Small-Cell Lung Cancer
- Combined Modality Treatment of Small Cell Carcinoma of the Lung
- “The state of the art” toward defining the role of radiation therapy in the management of small cell bronchogenic carcinoma
- “Total” therapy for oat cell carcinoma of the lung